Skip to main content
Premium Trial:

Request an Annual Quote

Zyomyx Seeks to Rise from the Ashes as Tech-Development Company

NEW YORK, Nov. 16 (GenomeWeb News) - Protein array pioneer Zyomyx today announced a new business strategy built on alliances, breaking its month-long silence after reports of massive lay-offs and an auction of much of its equipment.

 

Instead of bringing its own products to market, the company will now seek to develop products and technologies on behalf of partners. Zyomyx will focus on proteomics, molecular diagnostic, medical devices, and other industrial applications of its expertise.

 

The company will also continue to offer existing protein array products through a "streamlined service model."

 

"Our expertise and intellectual property in protein chip technologies, bio-interfaces and micro-scale bio-analysis are substantial, and we intend to accelerate the process already underway of building alliances with partners and customers to apply" these technologies, Peter Wagner, the company's new CEO and former chief technology officer, said in a statement.

 

Zyomyx did acknowledge an auction of "surplus" equipment and a "new lean structure" but did not mention lay-offs specifically in its statement.

The Scan

Study Tracks Responses in Patients Pursuing Polygenic Risk Score Profiling

Using interviews, researchers in the European Journal of Human Genetics qualitatively assess individuals' motivations for, and experiences with, direct-to-consumer polygenic risk score testing.

EHR Quality Improvement Study Detects Demographic-Related Deficiencies in Cancer Family History Data

In a retrospective analysis in JAMA Network Open, researchers find that sex, ethnicity, language, and other features coincide with the quality of cancer family history information in a patient's record.

Inflammatory Bowel Disease Linked to Gut Microbiome Community Structure Gradient in Meta-Analysis

Bringing together data from prior studies, researchers in Genome Biology track down microbial taxa and a population structure gradient with ties to ulcerative colitis or Crohn's disease.

Ancient Greek Army Ancestry Highlights Mercenary Role in Historical Migrations

By profiling genomic patterns in 5th century samples from in and around Himera, researchers saw diverse ancestry in Greek army representatives in the region, as they report in PNAS.